The 19 references in paper M. Zhuravleva V., V. Kukes G., Yu. Olefir V., B. Romanov K., A. Prokofiev B., S. Serebrova Yu., G. Gorodetskaya I., V. Arkhipov V., N. Lazareva B., М. Журавлева В., В. Кукес Г., Ю. Олефир В., Б. Романов К., А. Прокофьев Б., С. Сереброва Ю., Г. Городецкая И., В. Архипов В., Н. Лазарева Б. (2018) “Типовые инструкции по медицинскому применению взаимозаменяемых лекарственных препаратов: анализ современных документов, регулирующих их подготовку // Standard instructions for medical use of interchangeable drugs: analysis of modern regulatory documents” / spz:neicon:vedomostincesmp:y:2016:i:4:p:9-14

1
Federal Law of 22.12.2014, ¹ 429-FZ «On Amendments to the Federal Law ¹ 61-FZ «On Circulation of Medicines» (in Russian).
(check this in PDF content)
2
Decree of Government of the Russian Federation of 28.10.2015, ¹ 1154 «On the procedure for determining the interchangeability of drugs for medical use» (in Russian).
(check this in PDF content)
3
Federal Law of 21.11.2011, ¹ 323-FZ «On the bases of the health care of citizens in the Russian Federation» (in Russian).
(check this in PDF content)
4
Federal Law of 12.04.2010, ¹ 61-FZ «On Circulation of Medicines» (in Russian).
(check this in PDF content)
5
The list of assignments of Chairman of the Government of the Russian Federation of 01.07.2014, ¹ DM-P36 – 4825 (in Russian).
(check this in PDF content)
6
Helsinki Declaration of the World Medical Association «Ethical Principles for Medical Research with human as a subject» (in Russian).
(check this in PDF content)
7
The meeting of the CIS Economic Council of 17.06.2015, ¹ 66, St. Petersburg. The decision of the CIS Economic Council «On the state of competition in product markets medicines CIS member states». The report «On the state of competition in product markets medicines CIS member states» (in Russian).
(check this in PDF content)
8
The order of the Board of the Eurasian Economic of 29.12.2015, ¹ 187. On the draft decision of the Council of the Eurasian Economic Commission «On approval of requirements for medical application of drugs and the general characteristics of drugs for medical use» (in Russian).
(check this in PDF content)
9
The order of the Board of the Eurasian Economic Commission of 29.12.2015, ¹ 187 «Template general characteristics of the drug». The application ¹ 10 to the Requirements for instructions on medical use of the drug and the general characteristics of the drug for medical use (in Russian).
(check this in PDF content)
10
Guidelines «Preparing text for medical use of the drug instructions». FGU «NÑESMP»; 2009 (in Russian).
(check this in PDF content)
11
Handbook RLS. Section «Medicine chest to test the interaction». Available from: www.rlsnet.ru (in Russian).
(check this in PDF content)
12
Otdelenov VA, Novakova AN, Karasev AV, Yashina LP, Payuschik SA, Sychev DA, et al. Evaluation of the frequency of potentially significant drug interactions in patients with polypharmacy in a multidisciplinary hospital. Klinicheskaya farmakologiya i terapiya 2012; (5): 81–5 (in Russian).
(check this in PDF content)
13
Interactions checker. Available from: www.drugs.com.
(check this in PDF content)
14
Order of the Ministry of Health and Social Development of Russia of 26.08.2010 ¹ 748n «On approval of the issuance of permits to conduct clinical studies of a drug for medical use» (in Russian).
(check this in PDF content)
15
Order of the Ministry of Health and Social Development of Russia of 26.08.2010 ¹ 757n «On approval of the procedure of monitoring the safety of medicinal products for medical use, registration of adverse events, serious adverse reactions, unexpected adverse reactions in the use of drugs for medical use» (in Russian).
(check this in PDF content)
16
Berezovskaya IV, Guskova TA, Durnev AD. Guidelines for security studies of generic drugs. Biomeditsina 2011; (3): 78–80 (in Russian).
(check this in PDF content)
17
Beregovyh VV, Meshkovsky AP. Rationing pharmaceutical production. Moscow: Remedium; 2001 (in Russian).
(check this in PDF content)
18
Zherdev VP, Kolyvanov GB, Litvin AA, Sariev AK. Harmonization of bioequivalence studies of drugs: problems and their possible solution. Eksperimentalnaya i klinicheskaya farmakologiya 2003; (2): 60–4 (in Russian).
(check this in PDF content)
19
Konyushkova AN, Savchenko AYu, Davydova KS, Ramenskaya GV, Kukes VG. Review of the requirements for bioequivalence studies of generic drugs. FDA Requirements. Remedium 2011; (5): 54–7 (in Russian). AUTHORS
(check this in PDF content)